PubMed=9685856; DOI=10.1111/j.1349-7006.1998.tb03293.x
Fernandez J.E., Prados J., Melquizo C., Arena N., Malavasi F., Alvarez L., Aranega A.
Characterization of a new human embryonal rhabdomyosarcoma cell line, RMS-GR.
Jpn. J. Cancer Res. 89:525-532(1998)

PubMed=10470293; DOI=10.1111/j.1349-7006.1999.tb00816.x
Prados J., Melguizo C., Marchal J.A., Velez C., Alvarez L., Aranega A.
Multidrug resistance phenotype in the RMS-GR human rhabdomyosarcoma cell line obtained after polychemotherapy.
Jpn. J. Cancer Res. 90:788-793(1999)

PubMed=23882450; DOI=10.3389/fonc.2013.00183
Hinson A.R.P., Jones R., Crose L.E.S., Belyea B.C., Barr F.G., Linardic C.M.
Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls.
Front. Oncol. 3:183.1-183.12(2013)

PubMed=23665679; DOI=10.1038/onc.2013.129
Sokolowski E., Turina C.B., Kikuchi K., Langenau D.M., Keller C.
Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma.
Oncogene 33:1877-1889(2014)